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ABSTRACT Regions of both colicin Ia and diphtheria toxin N-terminal to the channel-forming domains can be translocated
across planar phospholipid bilayer membranes. In this article we show that the translocation pathway of diphtheria toxin allows
much larger molecules to be translocated than does the translocation pathway of colicin Ia. In particular, the folded A chain of
diphtheria toxin is readily translocated by that toxin but is not translocated by colicin Ia. This difference cannot be attributed to
speciﬁc recognition of the A chain by diphtheria toxin’s translocation pathway because the translocation pathway also accom-
modates folded myoglobin.
INTRODUCTION
A number of toxins (e.g., cholera, ricin, diphtheria, tetanus,
anthrax) act by having an enzymatic moiety that, when
delivered to the cytosol, ultimately leads to cell death. Gill (1)
named these ‘‘A-B toxins’’: the ‘‘A’’ portion is the active,
enzymatic part of the toxin, and the ‘‘B’’ portion is the part of
the toxin that binds to the cell membrane and through whose
agency the A portion is translocated to the cytosol. In some
cases (e.g., ricin and cholera toxin), translocation is achieved
through the utilization of the cell’s own translocation
machinery (2), but in other cases (e.g., diphtheria toxin and
anthrax toxin), all of the translocationmachinery is built into a
part of the Bmoiety, as manifested by its ability to translocate
the A component across a planar lipid bilayer without the aid
of any cellular components (3–5).
What is the mechanism of translocation? The B portion of
these toxins makes pores (also called channels) in planar lipid
bilayers (6,7), andmutants that are defective in pore formation
are also defective in intoxicating cells (8,9), making it tempt-
ing to suggest that the pore lumen acts as a conduit for the A
moiety. Although this has indeed been shown to be the case
for anthrax toxin (5), there is no conclusive evidence that the
pore is the translocation path for the other channel-forming
toxins. (Koriazova and Montal (4) claim to have established
this as the translocationmechanism for botulinumneurotoxin.
However, a more likely explanation for the blocking of the
channel by the A chain, which they claim as evidence for this,
is that it results from theAchain blocking the channel from the
trans side after it has been translocated across the membrane
to that side.) In this article, we demonstrate that the trans-
location pathway for the A chain of diphtheria toxin is large
enough to accommodate the folded chain (although we make
no claim that the pathway is through the pore lumen). We do
this by comparing the translocation pathway of diphtheria
toxin to that of colicin Ia.
Comparison of the channel-forming domains
and the channels formed by diphtheria toxin
and colicin Ia
The channel-forming domain of diphtheria toxin (the T
domain) and that of colicin Ia are about the same size (;175
residues). Each consists of a bundle of 10 a-helices, and in
both, helices 8 and 9 form a hydrophobic hairpin that is
(marginally) long enough to span the bilayer (10,11). There
is compelling direct evidence that the T domain channel is
monomeric, at least in our planar bilayer system (12), and
strong indirect evidence that the colicin Ia channel is as well
(13). The topographies of the open state of the two channels
have been mapped (14,15), and there are very interesting
similarities and differences between them (Fig. 1). In both,
the hydrophobic hairpin near the C-terminal end is inserted
into the bilayer to form two transmembrane segments (not
necessarily a-helices). For the T domain channel, there is
one additional transmembrane segment, making a total of
three, with everything upstream of it, including the A chain,
translocated across the membrane to the trans side. For the
colicin Ia channel there are two additional transmembrane
segments, making a total of four, with everything upstream of
it still on the cis side (the side to which the protein was added).
A summary of the relationship between the T domain and the
colicin Ia channel-forming domain is shown in Table 1.
The topography we have just described for the colicin Ia
channel, and shown in Fig. 1, is that formed by the whole
colicin Ia molecule, which has ;450 amino acid residues
N-terminal to the channel-forming domain. If formed from
the channel-forming domain alone, the channel ﬁrst goes
through a four-transmembrane-segment state as shown in
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Fig. 1 but then ends up in a three-transmembrane-segment
state, comparable to that formed by the T domain, with every-
thing upstream of the third transmembrane segment trans-
located across the membrane to the trans side (16) (Fig. 2). The
transition time between the four- and three-transmembrane-
segment state (i.e., the dwell time in the four-transmembrane-
segment state) is a function of the diameter of the molecular
‘‘stopper’’, or upstream sequences, attached to the N-terminus
of the channel-forming domain: the larger its size, the longer
the dwell time (17); if the stopper diameter is too large, the
channel remains in the four-transmembrane-segment state be-
cause the pathway is not wide enough to accommodate the
stopper.
What is the relevance of this to the pathway formed by the T
domain for the translocation of theA chain of diphtheria toxin?
In contrast to colicin Ia, one does not see an intermediate four-
transmembrane-segment state for the T domain channel, even
with the A chain attached at its N-terminus. Why is the
translocation of the A chain so rapid that it does not reveal this
state? Is it because its;200-residue peptide chain is unfolded,
or is the translocation pathway so wide that even the folded
chain can go rapidly through it, without lingering in a four-
transmembrane-segment state like colicin Ia? We address this
question here by looking at A chain translocation, or failure to
translocate, when it is attached to the N-terminus of the colicin
Ia channel-forming domain.We argue from our results that the
translocation pathway created by the T domain is much wider
than that created by colicin Ia’s channel-forming domain,wide
enough to easily accommodate the folded A chain.We further
show that the translocation pathway is not speciﬁc for the A
chain, because the T domain of diphtheria toxin can also
translocate folded myoglobin (MG).
MATERIALS AND METHODS
Synthesis of A-Ia
Plasmid pKSJ282 expressing the A chain of diphtheria toxin attached at the
N-terminus of the colicin Ia channel-forming domain (A-Ia) was constructed
as follows. Plasmid pKSJ155, which expresses a protein called Ia CT-M
(16), has residues 438–626 of colicin Ia, as well as the colicin Ia immunity
protein, cloned between the Xho I and BamH I sites of pET15-b (Novagen,
Madison, WI). This plasmid has an intact Nde I site immediately upstream
of the XhoI site, which is downstream from the translation initiation site,
histidine-tag (His6-tag), and thrombin recognition sequences of pET15-b.
The plasmid was digested ﬁrst with Nde I (New England Biolabs, Beverly,
MA), and the resulting DNA was cleaned up using the QIAquick PCR
Puriﬁcation Kit (Qiagen, Valencia, CA). The DNA was then digested with
Xho I (New England Biolabs), treated with calf intestine alkaline phos-
phatase (New England Biolabs), and gel-puriﬁed. A DNA fragment contain-
ing the sequence for diphtheria toxin A chain (DTA), but with the cysteine
at position 186 mutated to serine, was isolated by PCR from plasmid
LFN-DTA (C186/S) (18) containing LFN (the N-terminal portion of
anthrax toxin lethal factor) and DTA with C186/S separated by a spacer
FIGURE 1 Diagrams of the topographies of the colicin Ia and diphtheria
toxin channels. The colicin Ia channel has four transmembrane segments,
and the upstream N-terminal domains remain on the cis side. The diphtheria
toxin channel has three transmembrane segments, and the entire N-terminal
region, including the A chain, has been translocated to the trans side. H1,
H2-5, and TH1-4 refer to a-helices in the water-soluble forms of colicin Ia
and diphtheria toxin, respectively; they are not necessarily a-helices in the
channel state of these proteins.
TABLE 1 Comparison of the channel-forming domains and
the channels formed by diphtheria toxin and colicin Ia
Characteristics Colicin Ia Diphtheria toxin
Number of residues in
channel-forming domain
;175 ;175
Crystallographic structure of
water-soluble form
10 a-helices 10 a-helices
Number of protein subunits
forming the channel
1 1
Number of transmembrane
segments in the channel
4 (Whole colicin)
3 (Channel-forming
domain)
3
Two of the transmembrane
segments are formed by
hydrophobic hairpins
Yes Yes
FIGURE 2 Schematic of a single-channel record obtained from a bilayer
treated with the channel-forming portion of colicin Ia. The channel initially
opens to the same conductance as that obtained with whole colicin Ia; the
topography corresponding to this state has four transmembrane segments,
with H1 being one of these segments. (Compare this diagram with that for
whole colicin Ia in Fig. 1.) The conductance subsequently drops to a lower
conductance; the topography corresponding to this state has three transmem-
brane segments, with H1 having been translocated to the trans side. H1 and
H2-5 refer to a-helices in the water-soluble form of colicin Ia; they are not
necessarily a-helices in the channel state of this protein.
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sequence of 18 residues that includes His6. The forward PCR primer, 59-
GCGCCATATGGGTGCTGACGACGTTGTTGAC-39, creates an Nde I
site before the ﬁrst codon for DTA. The reverse primer, 59-GCGCCTCGA-
GACGGTTACCTGCAGAAGCCT-39, creates an Xho I site at the end of
the DTA gene and omits the translation terminator, so the protein reads
through. The resulting puriﬁed PCR fragment of ;580 base pairs was
ligated with the digested pKSJ155 to create pKSJ282. The protein expressed
from pKSJ282 thus has the initiation and His6-tag and thrombin-recognition
sequences from pET15-b, followed by the entire DTA sequence, a two-
amino-acid linker encoded by the Xho I site, followed by residues 438–626
of colicin Ia (the channel-forming domain). A schematic representation of
the fusion protein (DTA-Ia) is shown in Fig. 3.
Protein was expressed and puriﬁed from pKSJ282 in E. coli BL21(DE3)
that was induced for 2 h with 1 mM isopropyl-b-D-thiogalactopyranoside
(IPTG). Cells were harvested by centrifugation, resuspended in binding
buffer 1 (20 mM sodium phosphate, pH 7.4, 500 mM NaC1, 10 mM
imidazole), broken in an Emulsiﬂex C5 cell disrupter (Avistin, Ottawa,
Canada), and then centrifuged at 150,0003 g to remove cellular debris. The
clariﬁed extract from 1 liter of culture, in 40 ml binding buffer 1, was loaded
onto a 1-ml His Trap HP nickel chelation column (Amersham Biosciences/
GE Healthcare, Piscataway, NJ). The column was washed with 25 column
volumes of binding buffer 1, then with 10 volumes of the same buffer
containing 30 mM imidazole, and puriﬁed DTA-Ia (abbreviated A-Ia) was
eluted with 250 mM imidazole in binding buffer 1. The yield of puriﬁed
protein was ;15 mg of protein; although the stated capacity of this column
was $40 mg, there was a signiﬁcant amount of product protein that did not
bind to the column.
Puriﬁed A-Ia was dialyzed into 20 mM Tris-Cl, pH 8.4, 150 mM NaCl
before removal of the His6-tag by digesting the protein with 1 unit of
thrombin (Novagen) per milligram of puriﬁed protein for 5 h at room
temperature. The reaction was stopped by addition of phenylmethylsulfonyl
ﬂuoride to a concentration of 1 mM. Polyacrylamide gel electrophoresis
conﬁrmed that the digestion was complete. The resulting protein thus begins
with the glycine after the arginine residue in the thrombin-recognition
sequence (see Fig. 3). The protein was stored at 20C at a concentration of
2 mg/ml. Aliquots were taken and diluted at least 100-fold for the single-
channel experiments.
Synthesis of MG-T
The MG-T chimera contained (from N- to C-terminus) a His6-tag
(MGSSHHHHHHSSGLVPRGSH) fused to the sequence of sperm whale
myoglobin (MG) (19), followed by a linker (SAGNIEG) and then T domain
(residues 193–378 of diphtheria toxin). Construction of MG-T was based on
three-step PCR (20). The 59 primer contained an Nde I restriction site and
an N-terminal MG sequence. The internal forward primer contained the
C-terminal MG sequence, the linker sequence, and the N-terminal T domain
sequence. The internal reverse primer was complementary to the internal
forward primer. The 39 primer contained a sequence complementary to the
C-terminal of the T domain and a Not I restriction site. The ﬁrst PCR step
used the 59 primer, internal reverse primer, and template plasmid with the
corresponding MG gene. The second PCR step used the internal forward
primer, the 39 primer, and the plasmid template with the T domain gene.
These PCR products were puriﬁed by agarose electrophoresis, mixed, and
then subjected to several PCR cycles. Then the 59 primer and the 39 primer
were added, and a 40-cycle PCR was performed. The product sequences
were puriﬁed on agarose gel and inserted into plasmid pET-28a using
restriction sites Nde I and Not I. DNA sequencing conﬁrmed that the ﬁnal
construct had the correct sequences.
A pET-28a plasmid containing the MG-T insert was transformed into E.
coli strain BL21(DE3). A single colony was picked to inoculate 20 ml LB
medium containing 50 mg/ml kanamycin at 37C. The overnight culture was
transferred to 2 L LB medium containing 50 mg/ml kanamycin, grown at
37C until the OD600 reached 0.6, and then induced with 250 mg/ml IPTG
for 3 h. Cells were collected by centrifugation and stored temporarily at
20C. Cells were suspended in binding buffer 2 (20 mM Tris-HCl, pH 8.0,
150 mM NaCl) containing 100 mg/ml lysozyme. After incubation at room
temperature for 30 min, the sample was sonicated on ice using a probe
sonicator until the suspension was no longer viscous. The sonicated extract
was then centrifuged at 20,000 3 g at 4C for 20 min. The supernatant
containing MG-T was puriﬁed with TALON Metal Afﬁnity Resin from
Clontech (Mountain View, CA). One milliliter of TALON beads was
washed twice with .5 volumes binding buffer 2 and then mixed with the
supernatant from the cell extract. The mixture was agitated gently for 20 min
to allow the His6-tagged protein to bind to the resin. The beads were
collected by low-speed centrifugation and transferred to a 10-ml gravity-
ﬂow column. The column was washed three times with 5 ml binding buffer
2, and then the protein was eluted with 3 ml elution buffer (binding buffer 2
plus 200 mM imidazole). MG-T was further puriﬁed by Source Q anion
exchange chromatography. The sample was diluted to 50 ml with 20 mM
Tris-HCl, pH 8.0, and then loaded onto the Source Q column. The protein
was eluted by a salt gradient (20 mM Tris-HCl, pH 8.0, 0 to 0.5 M NaCl).
The purity of the isolated protein (.90%) was conﬁrmed by SDS-PAGE,
and protein concentration was determined using the Bradford assay.
Previous studies have shown that myoglobin binds hemin tightly at both
low and neutral pH (21). We conﬁrmed that MG-T also binds hemin tightly.
Addition of MG-T to hemin at pH 8 resulted in a change in the hemin
absorbance spectrum from that of free hemin to that of hemin bound to
myoglobin (21). In addition, we conﬁrmed by titration with hemin that
MG-T is maximally bound to hemin at both pH 8.0 and 5.3. At both pH
values, when hemin was titrated into MG-T, maximal quenching of MG-T
tryptophan by bound hemin was observed when at most a modest molar
excess of hemin to myoglobin was added (data not shown).
T domain and T domain with the A fragment at
its N-terminus (A-T)
The T domain with the second serine after the (His)6 in the N-terminal His6-
tag mutated to a cysteine and then biotinylated was the same sample as that
used in the experiments described by Senzel et al. (22). The A-T with an
N-terminal His6-tag was the same as that used in the experiments of Oh et al.
(3). In a separate construct, biotin was attached to a genetically engineered
biotin-accepting site (23) at the N-terminus of the A chain of A-T.
Bilayer experiments
Planar phospholipid bilayer membranes (;50 mm in diameter) were formed
at room temperature by a modiﬁcation of the folded ﬁlm technique (24) as
described by Huynh et al. (25). The lipid used was asolectin (lecithin type II
S; Sigma Chemical Company, St. Louis, MO) from which neutral lipids
FIGURE 3 Linear sequence of the A-Ia construct used for these experi-
ments. The 190 residues of the A chain of DTA are preceded by the His6-tag
and thrombin recognition sequences from pET15-b and connected to the
channel-forming domain (residues 438–626) of colicin Ia by a two-amino-acid
linker encoded by the XhoI restriction site.
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were removed by the method of Kagawa and Racker (26). After the
membrane formed, channel-forming proteins to be tested were added to the
cis solution, and single-channel behavior was monitored. All of the A-Ia
experiments were done in symmetric salt solutions containing 1 M KC1,
5 mM CaCl2, 1 mM EDTA, and either 20 mMMES (pH 6.2), 20 mM malic
acid (pH 4.85 or 4.5), or 25 mM succinic acid (pH 4.0). The pH 6.2 solution
also contained urea at molar concentrations of 0, 2.13, 2.83, 4.25, 6.38, or
8.5. The A-T experiments were done with 1 M KC1, 5 mM CaC12, 1 mM
EDTA on both sides of the membrane and 20 mM MES, pH 6.2 in the cis
solution (the side to which A-T was added) and 20 mM HEPES, pH 7.2 in
the trans solution. MG-T experiments were done with 1 M KCl, 2 mM
CaCl2, 1 mM EDTA on both sides of the membrane and 30 mM MES, pH
5.3, on the cis side and 50 mM HEPES, pH 7.2, on the trans side. Experi-
ments were done under voltage-clamp conditions; the voltages are those of
the cis solution with respect to the trans solution, whose potential was held
at virtual ground. Currents were ﬁltered at 100 Hz by the chart recorder.
Tryptophan ﬂuorescence measurements
The tryptophan ﬂuorescence measurements on the urea-dependent unfolding
of diphtheria toxin A chain were made on a Shimadzu RF-5301PC spectro-
ﬂuorophotometer using a 1-cm pathlength quartz cuvette. A chain with an
N-terminal 19-residue His6-tag and a C186A substitution to avoid disulﬁde
bond formation was prepared as described previously (27). Emission spectra
were recorded from 310 to 500 nm using a 290 nm excitation. Both the ex-
citation and emission slit widths were 3 nm, and all spectra were autozeroed
at 500 nm. The protein concentrationwas 27mg/ml in 1MKCl, 20mMMES,
5 mMCaCl2, 1 mM EDTA, pH 6.2 and 0–8.5 M urea, with a sample volume
of 1 ml.
RESULTS
Colicin Ia experiments
At pH 4.85 or higher, the conductance of the channel formed
by the channel-forming part of colicin Ia with diphtheria
toxin’s A chain attached to its N terminus (A-Ia) was the same
as that of the four-transmembrane-segment state of colicin Ia;
transitions to the smaller conductance exhibited by the three-
transmembrane-segment state rarely occurred (Fig. 4 A). In
contrast, at pH 4.5, these transitions readily occurred (Fig. 4
B), and at pH4.0, theywere so rapid as to be sometimes almost
unresolvable at our 100-Hz ﬁltering (Fig. 4 C). (The record
shown in Fig. 4 C was selected to illustrate representative
resolvable transitions of varying durations.) The effect of pH
on transitions is even more dramatic than it at ﬁrst appears in
Fig. 4. As was previously shown, the dwell time in the four-
transmembrane-segment state becomes shorter as the voltage
is increased (16). Thus, the rare transitions occurring at 170
mV at pH 4.85 (none is seen in Fig. 4A) are inmarked contrast
to the readily occurring transitions at1 50mV at pH 4.5 (Fig.
FIGURE 4 Behavior of single channels formed by A-Ia under various
conditions of pH and urea concentrations. In all experiments, the membrane
separated symmetric solutions containing 1MKC1, 5mMCaC12, and 1mM
EDTA. In addition, the solutions contained (A) 20 mM potassium malate,
pH 4.85; (B) 20 mM potassium malate, pH 4.5; (C) 25 mM potassium
succinate, pH 4.0; (D) 20 mM MES, 2.13 M urea, pH 6.2; and (E) 20 mM
MES, 2.83 M urea, pH 6.2. After the membrane formed, A-Ia was added
to the cis solution at a concentration of: (A) 1 ng/ml; (B) 12 ng/ml; (C)
11 ng/ml; (D) 5 ng/ml; and (E) 7 ng/m1. The arrows mark the transitions
from the four-transmembrane-segment state to the three-transmembrane-
segment state (see Fig. 2). Note that although the dwell time in the four-
transmembrane-segment state is voltage dependent, becoming shorter as
the voltage is increased (16), we see in these representative records that there
is no transition at 170 mV at pH 4.85 (A), but there are rapid transitions at
only130 mV at pH 4.0 (C). That is, the lower the pH, the more readily is the
A chain translocated. Similarly, we see that at170 mV and pH 6.2, there are
no transitions observed in 2.13 M urea, even with four open channels (D),
whereas each of the two channels that are open in 2.83 M urea undergoes
transitions (E). (The rapid upward ﬂickerings seen in the records,
particularly at 170 mV, are to higher-conductance states and are typically
seen with colicin Ia channels.) The records were ﬁltered at 100 Hz by the
chart recorder.
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4 B) and are in even more striking contrast to the rapid
transitions seen at 1 30 mV at pH 4.0 (Fig. 4 C). In fact, at
voltages above 1 30 mV at pH 4.0, most of the transitions
were too rapid to be resolved at 100-Hz ﬁltering.
These results are explicable in terms of the known
unfolding of the A chain at low pH (28): the translocation
pathway created by the colicin Ia channel is large enough to
allow passage through it of the unfolded A chain but not large
enough to accommodate the folded chain. As an independent
indication that the state of A chain folding is relevant to its
translocation through the colicin Ia translocation pathway, we
looked at the effect of a denaturant, urea, on translocation. At
pH 6.2, A chain translocation did not occur in the absence of
urea and only rarely (not seen in the ﬁgure) in 2.13 M urea
(Fig. 4 D) but did occur frequently at urea concentrations of
2.83 M and above (Fig. 4 E). This correlates well with the
observation that at pH 6.2, the free A chain is folded at urea
concentrations of 0 to 2.13M and completely unfolded at urea
concentrations of 3.18 M and above, as measured by the
wavelength shift of tryptophan ﬂuorescence (Fig. 5).
Diphtheria toxin experiments
In contrast to the results just described for experiments with
A-Ia, we have never seen transitions with A-T (the A chain
attached to the N-terminus of the T domain) from a higher
conductance state to the three-transmembrane-segment state,
even at pH 6.2, where the A chain is folded; the channels
always initially open to the three-transmembrane-segment
state (Fig. 6 A). (The rapid channel closures at negative
voltages (Fig. 6 B) are a consequence of the histidine tag at
the N terminus of the A chain, which blocks the channels
from the trans side and thus demonstrates that the A chain
has been translocated to that side (3).) A possible explanation
FIGURE 5 Urea titration of DTA (C186A mutant) monitored by trypto-
phan ﬂuorescence. The exposure of DTA to increasing amounts of urea from
0 M to 8.5 M results in both a decrease in the ﬂuorescence intensity and a
red-shift of the emission maximum of the tryptophan ﬂuorescence spectrum;
both effects are consistent with the exposure of tryptophan residues to
aqueous solvent because of the unfolding of DTA. Shown are illustrative
spectra of DTA in 0 M (solid), 2.13 M (dots), 3.18 M (dash), and 8.50 M
(dot-dash) urea. (Inset) Plot of the emission maximum as a function of urea
concentration (open circles). The data are described (R2 ¼ 0.999) by a
sigmoidal function (dashed line) indicative of a two-state unfolding process.
The midpoint of the transition is 2.6 M.
FIGURE 6 Demonstration that channels formed by A-T do not initially
open to a resolvable higher-conductance state (characterized by four
transmembrane segments) before the translocation of the A chain, as does
A-Ia, but rather open directly to the conductance characterized by three
transmembrane segments, with the A chain already translocated to the trans
side. (A) Single-channel record. Before the start of the record, A-T (with a
His6-tag attached to the N-terminus) was added to the cis solution to a
concentration of 0.64 mg/ml; one channel had already inserted before the
voltage was stepped to170mV. Note that in contrast to the records shown in
Fig. 4 for A-Ia, the channels do not initially open to a higher conductance
before attaining their ﬁnal value. The membrane separated symmetric
solutions of 1MKC1, 5mMCaC12, 1mMEDTA, 20mMMES, pH 6.2. The
record was ﬁltered at 100 Hz by the chart recorder. (B) Macroscopic record
demonstrating that the A fragment has been translocated to the trans side.
Before the start of the record,A-T (with aHis6-tag attached to theN-terminus)
was added to the cis solution to a concentration of 10.7 mg/ml, and numerous
channels had been inserted. The record shows rapid closure when the voltage
was switched from 170 to 80 mV and rapid reopening when the voltage
was switched back from 80 to 170 mV; this behavior is characteristic of
that obtained with a His6-tag attached to an A chain that has been translocated
to the trans side (3). The solutions on both the cis and trans sides of the
membrane contained 1 M KC1, 5 mM CaC12, and 1 mM EDTA. During the
insertion of the channels before the start of the record, the cis solution also
contained 20 mM MES, pH 6.2, and the trans solution contained 5 mM
HEPES, pH 7.2. The trans solution was then lowered to pH 5.6 with 5 mM
potassium succinate, and the above record was obtained. (If A-T channels
have inserted at cis pH 6.2, they do not show His6-tag gating if the trans pH
is 7.2, or even 6.2. We hypothesize that this is because the A chain has
been translocated in its folded state and in this state sterically inhibits the
N-terminal His6-tag from interacting with the channel. By our lowering the
trans pH to 5.6 after theA chain has been translocated, theA chain has unfolded
sufﬁciently, we believe, to allow the N-terminal His6-tag to interact with the
channel.) The record was ﬁltered at 100 Hz by the chart recorder.
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for this observation is that the T domain actually does initially
form a four-transmembrane-segment channel before going to
the three-transmembrane-segment channel, but that these two
channel structures, unlike those formed by colicin Ia, have the
same single-channel conductance. This explanation, however,
is not tenable. If the large-diameter, tightly folded streptavi-
din, instead of the A chain, is attached to the N-terminus of
the T domain, which forces the N-terminus to remain on the
cis side, then one indeed sees a larger-conductance channel
(Fig. 7 A), which presumably has four transmembrane seg-
ments. We have no direct evidence that this large-conductance
channel has four transmembrane segments and make this
presumption purely by analogy to our previous results with
colicin Ia (17). Its transmembrane topography, however, is
not relevant to the main conclusion that can be drawn from
the experiment. Namely, if there were an observable inter-
mediate channel state as the A chain translocates to the trans
side, the conductance of that intermediate channel would not
be the same as that of the ﬁnal, three-transmembrane-segment
channel. Interestingly, if streptavidin is attached to the
N-terminus of A-T, an ill-deﬁned, ‘‘junky’’ conductance re-
sults (Fig. 7 B). It is as if A chain insertion into the trans-
location pathway, without being able to fully translocate
because it is trapped by streptavidin at its N-terminus, creates
an unstable structure, or structures, instead of a stable channel
state.
It is possible that the rapid translocation of the folded A
chain by the T domain of diphtheria toxin (Fig. 6), in contrast
to its inability to be translocated by the channel-forming
domain of colicin Ia (Fig. 4,A andD), is a consequence of theT
domain being optimized to speciﬁcally aid in the unfolding of
the A chain; i.e., the T domain translocation pathway cannot,
in general, accommodate much larger molecules than can the
colicin Ia translocation pathway. This is unlikely, however, a
priori, on two counts: ﬁrst, in the crystal structure of diphtheria
toxin, the A chain is folded (10), and second, in the whole
toxin, the A chain retains its enzymatic activity (29), demon-
strating that the T domain has not promoted its unfolding in
free solution. This still leaves the possibility that when the T
domain associates with a lipid bilayer, it speciﬁcally aids the
unfolding of the A chain, and it is only the unfolded chain that
can be translocated. This, too, is unlikely, given that the T
domain’s translocation pathway readily lets through myo-
globin (Fig. 8, A and B) attached (by gene fusion) at the
N-terminus of the T domain. The minimal cross-sectional
diameter of 47 A˚ for myoglobin (30) is essentially the same as
the 44 A˚ minimal cross-sectional diameter of the folded A
chain (31). (Theminimal cross-sectional diameter is deﬁned as
the diameter of the smallest circle that can be drawn around the
projected image of the space-ﬁllingmodel of themolecule and
was determined as described by Kienker et al. (17).)
DISCUSSION
Both the channel-forming domain of colicin Ia (the ;175-
residueC-terminal end) and that of diphtheria toxin (its;175-
residue T domain) form channels having three transmembrane
segments (15,16), but whereas colicin Ia reaches this state by
FIGURE 7 Channel behavior when the N-terminus of
either the T domain (A) or A-T (B) is forced to remain on
the cis side. A cartoon for each of the resulting states is
shown on the left side of the panel. (A) Channel formed by
the T domain with streptavidin bound to the biotinylated
cysteine in the N-terminal His6-tag. The cis solution con-
tained 0.3 mg/ml of T domain whose N-terminal His6-tag
was biotinylated and had been preincubated with strepta-
vidin. Note the large size of this channel. (The arrow
marks a substate having the same conductance under the
pH conditions of the experiment as that of a channel with-
out streptavidin attached. We speculate that the switches to
a smaller conductance level seen in this trace result from
the lateral movement within the bilayer of the fourth
transmembrane segment away from the others, thereby
generating a ‘‘normal’’ three-transmembrane-segment chan-
nel.) The topography of TH5 to TH9 in the cartoon is that
of the ‘‘normal’’ channel (15); in the ‘‘normal’’ channel,
everything N-terminal to TH5 resides on the trans side
(Fig. 1). The ‘‘B’’ in the cartoon stands for biotin. The
solutions on both the cis and trans sides of the membrane
contained 1 M KC1, 2 mM CaC12, and 1 mM EDTA;
the cis solution also contained 30 mM MES, pH 5.3, and
the trans solution contained 50 mM HEPES, pH 7.2. The
applied voltage is 160 mV. (From Gordon (33).) (B)
Activity generated by A-T with streptavidin bound to a
biotin at the N-terminus of the A chain. The cis solution contained 35 ng/ml A-T biotinylated at its N-terminus and 20 mg/ml streptavidin that was present
before the addition of A-T. Note the erratic current ﬂuctuations and lack of a clear channel conductance state. The membrane separated symmetric solutions of
1 M KC1, 5 mM CaC12, 1 mM EDTA, 20 mM potassium malate, pH 4.85. The applied voltage is 160 mV.
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ﬁrst passing through an observable channel state with four
transmembrane segments ((16); Fig. 2), no such four-
transmembrane-segment channel state is normally observed
for diphtheria toxin. A possible explanation for this difference
in behavior is that the translocation pathway created by the T
domain is much wider than that created by colicin Ia, and
hence, residues N-terminal to it, including the ;200-residue
A chain, do not get ‘‘hung up’’ in it but, rather, can rapidly pass
through. The results presented in this article strongly support
this explanation.
Although the translocation pathway of colicin Ia lets
through the unfolded A chain, it does not let through the
folded chain (Fig. 4). The rare translocation events that we
have seen of the A chain through colicin Ia’s translocation
pathway at pH 4.85 and at 2.13 M urea (pH 6.2) are probably
attributable to occasional transient unfoldings of the A chain
under these conditions. In contrast, the T domain’s translo-
cation pathway readily lets through the folded A chain (Fig.
6). Before this work, it was not clear whether the A chain was
folded or unfolded under the pH conditions in which we
observed its translocation by diphtheria toxin (3). By using the
colicin Ia translocation pathway as a measure of A chain
folding in amembrane system, we have shown that, above pH
4.85, the A chain is folded (Fig. 4). The large size of the T
domain’s translocation pathway is consistent with its readily
letting through myoglobin (minimal cross-sectional diameter
47 A˚ (30)) attached to the N-terminus of the T domain (Fig. 8)
and is sufﬁcient to account for its letting through the folded A
chain (minimal cross-sectional diameter 44 A˚ (31)) without
invoking any special molecular recognition of that entity. On
the other hand, there is a limit to the size of a folded protein
that can be translocated through the T domain’s pathway. In
particular, streptavidin (diameter 61 A˚ (32)) does not go
through (Fig. 7 A).
The relation of the protein translocation pathways for
diphtheria toxin and colicin Ia to their respective channels is
unclear. There is no evidence at present that the channels
themselves serve as the protein conduit. The size of the colicin
Ia pathway appears to be voltage dependent, suggesting lipid
involvement in its structure (17). Besides the differences in
the sizes of their protein translocation pathways, there may be
one other signiﬁcant difference between the pathways for
colicin Ia and diphtheria toxin. Namely, negative voltages
can readily drive ‘‘stoppers’’ (covalently folded proteins and
peptides) attached to the N-terminus of the colicin Ia channel-
forming domain back from the trans side (to which side they
were translocated) to the cis side (17); we have no indication
that this is equally true for diphtheria toxin. That is, once theA
chain has been translocated, it does not readily return to the cis
side in response to large negative voltages.
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